Recla, Jimarie .

HRN: 07-85-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/26/2026
02/27/2026
IV
500 Mg X 3 Doses
Q8
Sp 1 LTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: